REDWOOD CITY, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will provide a corporate update at the LD Micro Main Event VII Conference, being held December 2-4, 2014 at The Luxe Hotel in Los Angeles, California.
Codexis Presentation Details
About Codexis, Inc.
Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production. Codexis’ proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development – from research to manufacturing. For more information, see www.codexis.com.
Andrew McDonald, 646-597-6987
Kate Whelan, +46 72 216 98 49